Company / PP&E (Net)
Cocrystal Pharma, Inc. PP&E (Net) History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$453.0K
FY2021
5-year range
$431.0K / $591.0K
FY2017-FY2021
Trend
-23.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $431,000 to $453,000 over the past 2 years.
Based on SEC 10-K filings.
$453,000 in FY2021.
Improved from $431,000 to $453,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, pp&e (net) decreased 23.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | $453.0K | -23.4% |
| FY2020 | $591.0K | +37.1% |
| FY2019 | $431.0K | -22.0% |
| FY2012 | $552.6K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026